| Message: | Bremelanotide (formerly PT-141) is a compound under drug development by Palatin Technologies as a treatment for female sexual dysfunction, hemorrhagic shock and reperfusion injury. It functions by activating the melanocortin receptors MC1R and MC4R, to modulate inflammation and limiting ischemia. It was originally tested for intranasal administration in treating female sexual dysfunction but this application was temporarily discontinued in 2008 after concerns were raised over adverse side effects of increased blood pressure. As of March, 2012, Palatin is conducting a human Phase 2B study using a new subcutaneous drug delivery system that appears to have little effect on blood pressure.
Order Process and Tips :
How to proceed your orders :
Step 1 Please let me know the items you are favorable, quantities, and the destination country.
Step 2 You confirm all details, and offer us purchasing order.
Step 3 We send the detail price of our product and offer the suitable shipping method for reference.
Step 4 You confirm the order and pay money 100% in advance and send us the detailed contacting information, including contacting person/company, address, mobile number,ZIP code and your special requirements.
Step 5 We arrange the shipment according to your requirements, and tracking code will be offered after claiming the payment within 24h, then you can track your parcel at any moment.
Step 6 We offer after-sales service after you receive parcel.
|
my account
